2,N,N-TMT

2,N,N-TMT
Clinical data
Other names	2,N,N-Trimethyltryptamine; 2,N,N-TMT; 2-TMT; 2-Methyl-N,N-dimethyltryptamine; 2-Methyl-DMT; 2-Me-DMT
Routes of; administration	Oral
ATC code	None;
Legal status
Legal status	DE: NpSG (Industrial and scientific use only); UK: Class A;
Pharmacokinetic data
Duration of action	4–6 hours
Identifiers
	IUPAC name (2-(2-methyl-1H-indol-3-yl)-1-methyl-ethyl)dimethylamine;
CAS Number	1080-95-1 ;
PubChem CID	11820174;
ChemSpider	9994827;
UNII	P15UO6J3FK;
ChEMBL	ChEMBL7580;
CompTox Dashboard (EPA)	DTXSID801016967 ;
Chemical and physical data
Formula	C13H18N2
Molar mass	202.301 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES Cc1c(c2ccccc2[nH]1)CCN(C)C;
	InChI InChI=1S/C13H18N2/c1-10-11(8-9-15(2)3)12-6-4-5-7-13(12)14-10/h4-7,14H,8-9H2,1-3H3; Key:NDGCOWDSLVNLGE-UHFFFAOYSA-N;
	(verify)

2,N,N-Trimethyltryptamine (2,N,N-TMT or 2-TMT), also known as 2-methyl-N,N-dimethyltryptamine (2-methyl-DMT), is a tryptamine derivative. It is not a conventional psychedelic, but instead produces tactile enhancement and auditory distortion. The drug was described by Alexander Shulgin and reported in his book TiHKAL (Tryptamines I Have Known and Loved).